Category: Uncategorized

Shares of Stada Arzneimittel AG shares rose 2.5% Tuesday after the German drug maker said Bain Capital LLC and Cinven Group Ltd. were considering asking for regulatory permission to launch a new takeover offer. The financial investors’ earlier offer valuing Stada at 5.3 billion euros ($5.9 billion) fell through in June, as shareholders didn’t tender enough shares to reach the minimum acceptance required for the offer to go through. That offer was for €66 a share. Management at Stada are seen as preferring the Bain Capital-Cinven bid to a rival offer from Advent International Corp. and Permira. The generic drug maker in early June dropped its minimum acceptance level to support its preferred suitors, but the bid still failed.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

New Jersey has reportedly made a state budget deal that will end the three-day-old government shutdown in time to reopen state parks and beaches for the Fourth of July, NJ Advance Media reported late Monday. Gov. Chris Christie is expected to approve the compromise bill after a late-night vote, NJ.com said. The resolution would also allow thousands of state government workers to return to their jobs. On Sunday, Christie was photographed sunbathing with his family on a beach closed to the public due to the shutdown, causing a furor.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

SpaceX scrubbed the scheduled launch of a communications satellite from Cape Canaveral, Fla., for the second day in a row Monday, saying it hopes to blast off Tuesday — potentially putting all other other Fourth of July rockets to shame. Sunday’s launch was canceled just 9 seconds before liftoff after a computer ordered the mission to abort. On Monday, Elon Musk’s SpaceX tweeted that the launch would be put off for at least one more day: “Standing down today due to a violation of abort criteria, vehicle/payload in good health, next launch opportunity tomorrow, July 4th!” Unlike recent launches, the Falcon 9 rocket — when it does lift off — will not land and be reused, since the heavier payload will require it to use all its fuel for the launch itself.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Tesla Inc. said on Monday that vehicle deliveries in the second quarter came to 22,000, up 53% from the year-earlier period. The Palo Alto, Calif., car maker cited a “severe” production shortfall of 100 kWh battery packs, which are made using new technologies on new production lines. “The technology challenge grows exponentially with energy density,” the company said in a statement. “Until early June, production averaged about 40% below demand.” Once the issue was resolved, June orders and deliveries were strong, “ranking as one of the best in Tesla history,” said the statement. For the first half, deliveries came to about 47,100 cars, compared with its most recent guidance of 47,000 to 50,000. Tesla said assuming global economic conditions don’t deteriorate, it is confident that deliveries of Model S and Model X in the second half will exceed the first-half number. Production totaled 25,708 vehicles in the second quarter, bringing first-half production to 51,126. Shares closed regular trading down 2.5% and were extending that loss in after-hours trade. The shares have gained 65% in 2017, while the S&P 500 has advanced 8.8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Sienna Biopharmaceuticals Inc. filed for an initial public offering to raise up to $74.8 million, according to a Securities and Exchange Commission filing late Monday. Westlake Village, Calif.-based Sienna develops topical dermatology therapies for conditions like psoriasis and acne. J.P. Morgan, Cowen and BMO Capital Markets are listed as underwriters for the offering. For the year ending 2016, the company reported no revenue and a net loss of $21.2 million. Sienna plans to list on the Nasdaq under the symbol “SNNA”.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Tesla Inc. said Monday second-quarter deliveries came to 22,000 vehicles, up 53% from the year-earlier period but well below the company’s guidance of 47,000 to 50,000 vehicles provided with its first-quarter earnings in May. The company said the main cause of the miss was a “severe” production shortfall of 100 kWh battery packs, which are made using new technologies on new production lines. “The technology challenge grows exponentially with energy density,” the company said in a statement. “Until early June, production averaged about 40% below demand.” Once the issue was resolved, June orders and deliveries were strong, “ranking as one of the best in Tesla history,” said the statement. For the first half, deliveries came to about 47,100 cars. Tesla said assuming global economic conditions do not deteriorate, it is confident that deliveries of Model S and Model X in the second half will exceed the first-half number. Production totaled 25,708 vehicles in the second quarter, bringing first-half production to 51,126. Shares closed regular trading down 2.5% and were extending that loss in after-hours trade. The shares have gained 65% in 2017, while the S&P 500 has gained 8.8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News